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Summary
Attenuation of RAS-mediated signalling is a conserved
process essential to control cell proliferation, differentiation,
and apoptosis. Cooperative interactions between histone
modifications such as acetylation, methylation and
sumoylation are crucial for proper attenuation in C.
elegans, implying that the proteins recognising these histone
modifications could also play an important role in attenuation
of RAS-mediated signalling. We sought to systematically
identify these proteins and found BET-1. BET-1 is a
conserved double bromodomain protein that recognises
acetyl-lysines on histone tails and maintains the stable fate
of various lineages. Unexpectedly, adults lacking both BET-1
and SUMO-1 are depleted of muscle myosin, an essential
component of myofibrils. We also show that this muscle
myosin depletion does not occur in all animals at a specific
time, but rather that the penetrance of the phenotype
increases with age. To gain mechanistic insights into this
process, we sought to delay the occurrence of the muscle
myosin depletion phenotype and found that it requires
caspase activity and MEK-dependent signalling. We also
performed transcription profiling on these mutants and
found an up-regulation of the FGF receptor, egl-15, a
tyrosine kinase receptor acting upstream of MEK.
Consistent with a MEK requirement, we could delay the
muscle phenotype by systemic or hypodermal knock down of
egl-15. Thus, this work uncovered a caspase- and MEK-
dependent mechanism that acts specifically on ageing adults
to maintain the appropriate net level of muscle myosin.
 2013. Published by The Company of Biologists Ltd. This
is an Open Access article distributed under the terms of
the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution and reproduction in any
medium provided that the original work is properly
attributed.
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Introduction
Controlling RAS-mediated signalling is crucial to promote or
inhibit cell growth, differentiation, and apoptosis in vertebrates.
Loss of control at the level of attenuation can lead to
hyperactivation of the pathway and in the worst cases
tumourigenesis. Over two decades of studies on RAS-mediated
signalling in C. elegans have shown that the epigenetic landscape
can impact on attenuation of the LET-60 (RAS) signalling
pathway and cell fate (Andersen and Horvitz, 2007; Ceol and
Horvitz, 2001; Fay and Yochem, 2007; Fisher et al., 2010; Lipsick,
2004; Lu and Horvitz, 1998; Poulin et al., 2005; Solari and
Ahringer, 2000). Many of the chromatin complexes depositing or
removing histone modifications have since been shown to act
redundantly to prevent ectopic expression of LIN-3 (EGF)
(Andersen and Horvitz, 2007; Andersen et al., 2008; Cui et al.,
2006). Ectopic expression of LIN-3 can lead to over activation of
the receptor tyrosine kinase, LET-23 (EGFR), and its conserved
downstream cascade: LET-60/LIN-45/MEK-2/MPK-1, RAS/
RAF/MEK/MAPK in mammals (Sundaram, 2006). It has also
been shown that the sumoylation pathway genetically interacts
with many of these chromatin complexes to attenuate LET-60
(RAS)-mediated signalling (Leight et al., 2005; Poulin et al.,
2005). SUMO is a conserved short polypeptide transferred onto
specific substrates (Gareau and Lima, 2010; Johnson, 2004), which
can be recognised by effector proteins through SUMO interacting
motifs (SIMs) (Geiss-Friedlander and Melchior, 2007; Kerscher,
2007). These effector proteins can in turn regulate specific
functions such as transcription, chromatin structure, genome
integrity, and DNA repair (Cuben˜as-Potts and Matunis, 2013;
Geiss-Friedlander and Melchior, 2007). Collectively, these studies
raised the possibility that post-translational modifications of
histones, such as sumoylation, methylation, and acetylation,
could form a combinatorial code recognised by specialised
proteins referred to as readers of the epigenetic code, which in
turn would regulate transcription of genes that prevent
hyperactivation of the LET-60 signalling pathway.
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We set out to identify readers that recognise chromatin
modifications and genetically interact with the sumoylation
pathway to prevent hyperactivation of the LET-60 signalling
cascade. We used RNAi to deplete all predicted readers and
identified CHD-3, HPL-2, and BET-1. CHD-3 and HPL-2 are
chromodomain proteins recognising methylated histone tails and
were previously shown to play a role in LET-60 attenuation
(Coustham et al., 2006; Solari and Ahringer, 2000). BET-1 is a
conserved double bromodomain protein of the BET family required
for establishment and maintenance of stable fate in various lineages
(Shibata et al., 2010). BET-1 shares homology with both human
BRD2 and BRD4, and is a likely homolog of BRD4 because of a
putative P-TEFb interaction motif not present in BRD2 (Bisgrove
et al., 2007). BET-1, like other BET proteins, physically associates
with acetyl-lysines on histone tails (Shibata et al., 2010).
Low molecular weight inhibitors such as JQ1 and I-BET151
can efficiently target acetyl-lysine binding sites of BET proteins
(Dawson et al., 2011; Delmore et al., 2011; Filippakopoulos et al.,
2010; Nicodeme et al., 2010; Zuber et al., 2011). In multiple
myeloma, the inhibition of BRD4 leads to downregulation of the
oncogenes c-MYC and other growth promoting and apoptotic
genes (Delmore et al., 2011). This specific transcriptional
regulation has recently been attributed to the effect of BRD4
on super-enhancers (Love´n et al., 2013).
Herein we performed a targeted RNAi screen and identified BET-
1 as a novel SUMO interactor. Unexpectedly, we found that SMO-1
and BET-1 act together to maintain net muscle myosin levels in
ageing adults. We show that muscle myosin depletion requires
caspase activities and the FGF receptor/MEK signalling pathway to
manifest. Interestingly, human caspases are activated under muscle
catabolic conditions induced by insulin resistance (Du et al., 2004).
Materials and Methods
Strains and general maintenance
Strains were maintained at 20 C˚ as described (Brenner, 1974), unless stated. For
full list of strains see supplementary material Table S2. Of note, the muscle
phenotype has been analysed using either bet-1(os46) or bet-1(gk425) but all
presented data are with bet-1(gk425).
Identification of putative readers of chromatin marks
To identify genes for use in the targeted RNAi screen, the Pfam accession number
for each domain of interest was used to filter the WormBase database (release
WS190), using the WormMart data mining tool.
RNAi experiments
RNAi screens of the ,200 gene set were performed similarly to those described
previously (Kamath et al., 2003; Poulin et al., 2005). Briefly, individual cultures
were used to inoculate three wells on a six-well plate (Poulin et al., 2005), around
10 synchronized smo-1/hT2 L3-L4 stage worms were placed in the upper well for
each bacterial strain and the plates maintained at 20 C˚. After 48 h, 5 worms from
the upper well were transferred to the lower well. The F1 progeny were scored for
the Mvp (multiple ventral protrusion) phenotype. RNAi clones giving Mvp in one
or more smo-1/hT2 animals and/or two or more smo-1/smo-1 animals were selected
for further analysis. These criteria took into account the 10% background Mvp in
smo-1/smo-1 animals. RNAi clones were obtained from the Ahringer RNAi library
(Kamath et al., 2003) and the Vidal RNAi library (Rual et al., 2004). All positive
RNAi clones were verified by sequencing. All further RNAi experiments were
performed similarly as described above.
Immunofluorescence staining of embryos and muscle myosin
Immunofluorescence of muscle myosin on embryos or adults was performed by
freeze crack method as previously described (Wang et al., 2011) with the following
adaptation for staining of adults: each mother was cut open in the middle using a
sharp needle. Four-day old adults (wild type or mutants) were grown from L1 on
OP50, picked onto slides and freeze cracked. Slides were incubated with anti-
myosin heavy chain A (5–6 (1:100) or 5–14 (1:100), Developmental Studies
Hybridoma Bank, University of Iowa) overnight at 4 C˚ in a humid chamber.
Following washes slides were then incubated with DyLight 594 AffiniPure Goat
Anti-Mouse IgG (H+L) (1:200) (cat.115-515-146, Jackson Immunoresearch).
Pictures were taken with same settings as control wild type and each batch was
systematically control with wild type.
Fluorescence Recovery After Photobleaching (FRAP)
For FRAP studies, full length bet-1 ORF was cloned into the pcDNA6.2/N-
EmGFP-DEST vector and verified by sequencing. Full length GFP-tagged bet-1
was reverse-transfected into U2OS cells using Fugene HD (Roche) and plated into
glass bottom dishes (World Precision Instruments, USA). Bromodomain FRAP
assays have been previously described (Filippakopoulos et al., 2010). Briefly,
FRAP was performed 24 hours after transfection using a Zeiss LSM 710 scanhead
coupled to an inverted Zeiss Axio Observer.Z1 microscope (406 oil immersion
objective) and an argon-ion laser (488 nm) with PMT detection set to 500–
550 nm. The HDAC inhibitor SAHA was added (5 mM, 4 hours post transfection)
to increase the assay window (BET binding increased) and JQ1 (2.5 mM) was
added 1 hour prior to FRAP. Approximately half of the GFP positive nucleus was
selected for bleaching and a time lapse series was taken to record GFP recovery
using 1% of the power used for bleaching. The image datasets and fluorescence
recovery data were exported from the microscope control software (ZEN 2009)
into GraphPad Prism to determine the half-time for full recovery for individual
cells and averages were calculated from 10–20 cells per treatment point.
Western blot analysis
Whole worm protein extracts at the indicated stages were prepared by harvesting
synchronized worms, washing the pellet in 16 PBS and boiling in 16 sample
buffer containing 100 mM DTT, and sonicating. Quantification performed using
ImageJ software.
Microarrays
Sample preparation: Whole worm extracts for microarray analysis were prepared
by placing ,50 mothers on 10 10 cm NGM plates for each strain. Gravid progeny
were bleached and the eggs put on NGM plates with no food. After 24 hours the
synchronised L1 were washed off and placed on plates with food. Once the F2
progeny had reached L4 the worms were harvested, washed once in M9 buffer and
frozen at 280 C˚.
RNA preparation: Two replicates of bet-1/+, smo-1/+ mutants, and smo-1, bet-
1/+ double mutants and the corresponding balancer strain as a control were
processed for microarray analysis. Nematode pellets were incubated with 1% beta-
mercaptoethanol and 800 mg/mL proteinase K at 55 C˚, 500 rpm shaking during
60 minutes. Total RNA was extracted from these pellets using RNeasy Micro kit
(Qiagen) according to manufacturer instructions.
Microarray analysis: The extracted RNA was processed for microarray
performance; the platform used for that purpose was C. elegans (V2) Gene
Expression Microarray 4644K (Agilent technologies), following manufacturer
instructions. Raw data (supplementary material Table S3) was extracted from the
scanned images by the Agilent feature extract software. Data was normalized in the
statistical programming environment ‘‘R’’ using the LIMMA package (Smyth,
2004). For within array normalization we used the Loess method and for the between
array normalization we used the quantile method. No background correction was
needed. A linear model was used to determine the differently expressed genes.
Quantitative RT-PCR
Worm pellets were prepared by harvesting synchronized L4 worms, washing the
pellet in 16PBS and freezing at280 C˚. Total RNA was extracted from these pellets
using TRIzol (Invitrogen) and first strand cDNA synthesis was performed using the
SuperScript VILO cDNA Synthesis Kit (Invitrogen), according to the
manufacturer’s instructions. Quantitative RT-PCR was performed using the
FastStart SYBR Green Master (ROX) mix (Roche) on a StepOnePlus Real-Time
PCR System (Applied Biosystems). Two biological samples for each strain were
prepared, and for every biological replicate, a triplicate of two serial dilutions was
analysed. act-1 was used as the internal reference for data normalization. mRNA
levels were determined by comparing the unknown samples to a standard curve of
known relative amounts. Primers used are listed in supplementary material Table S4.
JQ1 and U0126 treatments of nematodes
Synchromised L1 larvae were transferred onto NGM plates prepared with the
indicated concentration of JQ1 (Filippakopoulos et al., 2010) or U0126 (Morgan
et al., 2010).
Results
BET-1 genetically interacts with SUMO
Deposition and removal of post-translational modifications
(PTMs) on histone tails play an important role in
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transcriptional regulation, which in turn impacts on the process of
attenuation of LET-60-mediated signalling in C. elegans (Cui
et al., 2006; Lipsick, 2004; Lu and Horvitz, 1998; Poulin et al.,
2005). These PTMs can act by either altering the electrostatic
interactions between histones and DNA or by creating
recognition sites for specialised proteins often referred to as
readers of the epigenetic code (Kouzarides, 2007). To test the
latter mode of action, we performed an RNAi screen targeting all
known predicted readers (,200 genes; supplementary material
Table S1). Since the sumoylation pathway has been shown to
genetically interact with many chromatin complexes involved in
attenuation of LET-60 (Leight et al., 2005; Poulin et al., 2005),
we performed the screen in a SUMO-compromised strain
(smo-1lf /+). We selected our candidates according to the
observation of SUMO-associated phenotypes. The main expected
phenotype being the multivulvae (Muv) phenotype (Broday et al.,
2004; Leight et al., 2005; Poulin et al., 2005) and its superficial
manifestation the multiventral protrusion phenotype (MVP)
(Fisher et al., 2010); these phenotypes indicate hyperactivation
of the LET-60/LIN-45/MEK-2/MPK-1 signalling cascade. We
identified three candidates: two conserved chromodomain
proteins: CHD-3 (Solari and Ahringer, 2000) and HPL-2
(Coustham et al., 2006); and the double bromodomain BET-1.
We focused this study on BET-1, which was previously shown to
recognise acetyl-lysines on histone tails and to maintain cell fate
in various lineages (Shibata et al., 2010).
BET-1 and SUMO prevent muscle myosin depletion in adults
Following the identification of BET-1 by RNAi screening, we
generated the double mutant smo-1lf bet-1lf and assessed whether
we could detect a genetic interaction during vulva development.
Surprisingly, we could not find an interaction in the vulva.
Instead, we found that the single bet-1lf mutant or RNAi against
bet-1 can produce the Muv (multiple vulvae) phenotype, but the
additional loss of smo-1 does not aggravate the Muv phenotype
(data not shown). However, during these investigations, we
noticed that an important proportion of these double smo-1lf bet-
1lf mutants lost their ability to crawl early in adulthood. We
quantified this observation by assessing loss of locomotion. In
this established assay (Herndon et al., 2002), locomotion can fall
into three exclusive categories: fully mobile (A), mobile
following prodding (B), immobile (C). This latter category is
defined by animals incapable of producing a full body movement
following prodding whilst remaining alive, which is determined
by head movements. We measured loss of locomotion from larval
stage 1 (L1) for each single mutant, the double mutant, and wild
type. We found that a proportion of the single bet-1lf or smo-1lf
mutant lost locomotion earlier than wild type (4.5%, n544; and
23%, n548, respectively). However, the decline in locomotion is
accelerated and more penetrant in the double smo-1lf bet-1lf
mutants (73%, n545). The double smo-1lf bet-1lf mutants are
statistically different (Fisher’s exact test) from N2 and the singles
(P5461029 (compared with N2), 0.161029 (compared with bet-
1lf), 3610
26 (compared with smo-1lf); Fig. 1A; supplementary
material Fig. S1). Further, to provide an overview of the life
history of each population, we present the entire dataset as box
plots from day 1 till day 21. The number of days spent in each
category for each strain at a specific time point can be selected
(supplementary material Movie 1) or alternatively the entire 21-
day assay can be viewed as a movie (supplementary material
Movie 1) showing how the population for each category changes
according to time. In conclusion, the locomotion assay shows that
BET-1 and SMO-1 can act individually and in cooperation to
prevent loss of locomotion in adults.
Time-associated loss of locomotion is a natural phenomenon
attributed to a failure of maintaining a functional ageing muscle
mass (Herndon et al., 2002). We therefore explored the
possibility that the bet-1lf and smo-1lf mutants are experiencing
a decline in muscle functionality. To test this, we directly
measured muscle myosin (MYO-3), a major component of
myofibrils, using immunofluorescence stainings and Western blot
analysis. We first surveyed the levels of adult muscle myosin by
immunostainings on wild type animals versus singles and double
mutants. We used a modified freeze-crack method, which
involves cutting open the mothers roughly in the middle,
allowing the antibody to penetrate thoroughly the muscles. All
wild type animals are successfully stained using this adaptation.
At day one of adulthood, we found that the MYO-3 signal was
depleted in 4.7% of double smo-1lf bet-1lf mutants while all wild
type animals and the respective single mutants all remained
positive for MYO-3 (Fig. 1B). Interestingly, at day four of
adulthood, the phenotype reached a penetrance of 37.5% for smo-
1lf bet-1lf animals. A slight increase was observed with single
mutants (bet-1lf mutants: 2.7%; smo-1lf mutants: 4.8%) but no
effect was found on wild type (Fig. 1B; Table 1). One day later at
day five, the double smo-1lf bet-1lf reached 42.5% and the
respective single mutants about 10% (Fig. 1B). Depletion was
never observed in late embryos (Fig. 1C). Taken together, these
experiments indicate a time-associated defect in net levels of
muscle myosin for all mutants.
We next verified whether the observations obtained by
immunostainings could also be detected by Western blot
analysis, hence eliminating possible artefacts due to the
staining procedure. We prepared whole worm extracts from
double smo-1lf bet-1lf mutants and compared with extracts from
wild type animals at three time points: L4, day-one adults and
day-four adults. We found that muscle myosin levels are similar
at L4 and day-one adults, but depleted at four-day adults
(Fig. 1D). We quantified this effect relative to wild type sample
and found that levels of myosin are down to 68.8% in average for
smo-1lf bet-1lf samples (SEM 6.5%; n54). This is consistent with
our immunostaining experiments (Fig. 1B) and thus validates the
occurrence of the muscle myosin depletion phenotype. We also
observed degradation products from day-one adults, but only in
wild type animals, we do not know the significance of this
reproducible effect. Of note, we also confirmed the muscle
myosin depletion phenotype using a different antibody against
MYO-3 (supplementary material Fig. S2A). Moreover, we used
an antibody against paramyosin (supplementary material Fig.
S2B,C) and observed the same effect, i.e. immunofluorescence
shows that ,30% of double smo-1lf bet-1lf mutants are depleted
in paramyosin and Western blot analysis shows that paramyosin
is down to 66% in average (SEM 2.8%; n54).
Finally, our data from immunostaining and Western blot
analysis show that the muscle myosin depletion phenotype has an
onset in adults, but it does not rule out that the casual defect
occurs prior to adulthood, since the genetic deletions are always
present. To circumvent this problem, we performed acute smo-
1(RNAi) treatments on young bet-1lf adults followed by
immunostainings against MYO-3 on day four adults. We
observed that 28.1% (n534) of bet-1lf; smo-1(RNAi) are MYO-
3 depleted compared with 0% (n532) for the control RNAi
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treatment (P50.001; Chi square test of association). This
experiment using acute RNAi treatments against smo-1 on
young bet-1lf adults shows that the depletion of muscle myosin
phenotype can occur after the establishment of muscle
development and therefore provide further evidence that the
depletion of muscle myosin is consistent with a defect during
adulthood.
Caspase-dependent depletion of muscle myosin
Muscle myosin levels are regulated by both synthesis and
proteolysis. Since the phenotype described herein has an onset in
adulthood and that the bulk of muscle myosin is synthesised prior
to adulthood, we hypothesised that the depletion of muscle
myosin is more consistent with excessive degradation of muscle
myosin. There are four proteolysis systems described for
mammalian muscles: the proteasome (Mitch and Goldberg,
1996), the lysosome (Sandri, 2013), calpains (Sorimachi and
Ono, 2012) and caspases (Du et al., 2004). The first three have
been shown to function in C. elegans (Etheridge et al., 2012). We
reasoned that the proteasome and lysosome systems are unlikely
to be the primary system acting on muscle myosin because of
their inefficiency at directly targeting myofibrils components,
such as muscle myosin (Du et al., 2004). Calpains are activated
by disruption of the integrin attachment complex (Etheridge et al.,
2012), which produces a very different muscle phenotype than
the muscle myosin depletion phenotype. We therefore
investigated whether a caspase-mediated system could be
erroneously activated in smo-1lf bet-1lf double mutants. To test
this, we blocked the caspase cascade in smo-1lf bet-1lf mutants
using ced-3 or ced-4 loss of function mutants. CED-3 (the
Fig. 1. Loss of locomotion and depletion of muscle
myosin in smo-1lf bet-1lf animals. (A) Histograms of
cloned individual animals followed using a locomotion
assay from larval stage one (L1) until day four (D4) adult
showing that locomotion of the double mutants is
aggravated by the loss of both BET-1 and SMO-1. Blue
depicts crawling animals, red, animals requiring prodding,
green, immobile animals, and purple, dead animals.
(B) Immunostaining against MYO-3 showing double smo-
1lf bet-1lf mutants displaying a high frequency of the
depletion of muscle myosin phenotype at day four and five
adult (see Table 1 for quantification). This is observed in
all muscles but more pronounced in the posterior part of the
animal. Inset is a 5.46magnification. (C) Immunostaining
against MYO-3 showing that late embryos do not display
the depletion of muscle myosin phenotype. Inset is a 5.46
zoom in. (D) Western blot analysis using an anti-MYO-3
antibody showing that at day four adult, MYO-3 is
depleted. Ten age-matched animals were used for each
lane. We repeated the experiments four times and a
representative blot is shown. Scale bars: 100 mm (B),
10 mm (C).
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downstream caspase) and CED-4 (the apoptotic protease-
activating factor 1) are required for most apoptosis events
occurring in C. elegans (Ellis and Horvitz, 1986; Miura et al.,
1993). The triple smo-1lf bet-1lf; ced-3lf or smo-1lf bet-1lf; ced-4lf
mutants were analysed by immunostaining against muscle
myosin. We observed that most of these caspase-defective
triple mutants maintain muscle myosin levels at day four adult
(CED-3: 98% and CED-4: 95%; Fig. 2A; Table 1). We verified
this result using Western blots against MYO-3 and confirmed that
muscle myosin levels are in average higher in absence of SMO-1,
BET-1 and CED-3 than in absence of SMO-1 and BET-1 (127%,
SEM 3%, n54: Fig. 2B), albeit at levels remaining below the
wild type levels (Fig. 2B). Similar results were obtained using
the anti-paramyosin antibody (131%, SEM 8.6%, n53;
supplementary material Fig. S2D). Furthermore, we performed
the locomotion assay on the triple smo-1lf bet-1lf; ced-3lf mutants
and observe a significant increase in the proportion of animals
retaining locomotion for the triple smo-1lf bet-1lf; ced-3lf mutants,
when compared with the double smo-1lf bet-1lf mutants (from
67%, n545 to 27%, n545 at P50.0003; Fisher’s exact Test)
(Fig. 2C), indicating that inactivation of the caspase system
causes a delay rather than a rescue of the loss of locomotion
phenotype. We also present the delay effect as animated box
plots for each locomotion category and strain (supplementary
material Movie 2). Taken together, these results provide strong
evidence that a caspase system is functional to maintain muscle
homeostasis in C. elegans.
The muscle myosin depletion phenotype is MEK-dependent
Both sumoylation and BET-1 are important regulators of
transcription. We therefore postulated that changes in their
transcription profiles could provide insights into the muscle
myosin depletion phenotype. However, we met a technical
problem; we could not extract sufficient materials from single or
double smo-1lf bet-1lf homozygous escapers. To palliate to this
Table 1. Immunostaining analysis of muscle myosin levels at
day four adulthood to assess the muscle myosin depletion
phenotype. Not applicable (n/a) for egl-15 mutant or RNAi,
since the worms are egg laying defective and eventually burst
before any analysis can be conducted. Sterility avoids this
problem. The * indicates a P value,0.01 by Chi square test of
association. Demm: Depletion of muscle myosin.
Genotype N % Demm
Wild type 43 0
smo-1lf 63 0
bet-1lf 52 4*
smo-1lf bet-1lf 104 38
ced-3lf 69 3*
smo-1lf bet-1lf; ced-3lf 58 2*
ced-4lf 61 0
smo-1lf bet-1lf; ced-4lf 55 5*
EV (RNAi) 32 0
EV (RNAi); smo-1lf bet-1lf 162 34
EV (RNAi); smo-1lf bet-1lf; egl-15lf 129 22*
sur-7 (RNAi) 42 0
sur-7 (RNAi); smo-1lf bet-1lf 98 10*
sur-7 (RNAi); smo-1lf bet-1lf; egl-15lf 188 6*
egl-15 (RNAi); smo-1lf bet-1lf 106 15*
egl-15 (RNAi) n/a n/a
egl-15lf n/a n/a
clr-1lf 64 0
Fig. 2. Inactivation of CED-3 in double smo-1lf bet-1lf
mutants prevents depletion of muscle myosin and
improves locomotion. (A) Immunostaining against MYO-
3 showing that the depletion of muscle myosin phenotype
requires the caspase CED-3 to manifest. (B) Western blot
analysis showing that muscle myosin levels are increased
when compared with the double smo-1lf bet-1lf mutants. See
Table 1 for immunostaining results. (C) Locomotion assay
performed on cloned individual animals (as in Fig. 1A)
showing an improvement of locomotion when CED-3 is
inactivated. Blue depicts crawling animals, red, animals
requiring prodding, green, immobile animals, and purple,
dead animals. L1 to L4 stands for larval stages one to four,
and D1 to D4 stands for adult day one to four. Scale bar:
100 mm.
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issue, we instead used heterozygotes (see materials and methods).
As anticipated, transcription is not strikingly affected in these
heterozygous animals. However, focusing our analysis on known
components of the LET-60 signalling pathway, we found two
possibly up-regulated positive regulators of the pathway: egl-15,
(the FGF receptor; (DeVore et al., 1995)) and sur-7 (a cation
transporter (Yoder et al., 2004)) (Fig. 3A). To verify these
results, we performed quantitative RT-PCR on independent
biological samples (in the double smo-1lf bet-1lf heterozygous
background) and tested the levels of expression of six genes,
including the egl-15 and sur-7 candidates (Fig. 3B). We found
that both egl-15 and sur-7 are up-regulated significantly by about
2- and 1.5-fold, respectively (Fig. 3B), egl-15 showing a very
strong p-value (Fig. 3B). We also detected a slight up-regulation
(,1.3-fold) for let-60 (Fig. 3B). In contrast, cdf-1, ptp-2 and egl-
17 are not significantly affected (Fig. 3B). The up-regulation of
egl-15 is of interest since the FGF receptor can activate the LET-
60/MEK signalling pathway and when hyperactivated increase
muscle cells proteolysis as measured using a reporter assay
(Kokel et al., 1998; Sundaram, 2006; Szewczyk and Jacobson,
2003). On the other hand, SUR-7 has not been linked to
proteolysis in muscle cells, yet it acts as a positive regulator of
LET-60/MEK signalling by regulating levels of cytoplasmic zinc
ions through sequestration in the endoplasmic reticulum (Yoder
et al., 2004). It is also known that elevated levels of zinc ions
increase phosphorylation of the scaffold protein KSR, preventing
its association with RAF and MEK and instead favouring an
inhibitory association with 14-3-3 (Mu¨ller et al., 2001). Thus, up-
regulation of both EGL-15 and SUR-7 are consistent with an
increase in LET-60/MEK-mediated signalling.
These results from the expression profile data suggested the
possibility that the absence of BET-1 and SMO-1 could lead to
Fig. 3. Up-regulation of egl-15 and sur-7 in smo-1lf bet-
1lf mutants. (A) Transcription profiles obtained from
microarrays of smo-1lf /+, bet-1lf /+ and smo-1lf bet-1lf /+
indicate up-regulation of egl-15 and sur-7. The balance
strain (+/hT2) is used as a reference. Displayed as a colour
coded matrix are the results from 56 genes known to act
within the LET-60 signalling pathway. Black indicates no
change, blue and yellow indicate down- and up-regulation
in log2 scale, respectively. The raw data and calculated p-
values are available in supplementary material Table S3.
Microarray analysis for differential expression was per-
formed using the LIMMA (Linear Models for MicroArray
(Smyth, 2004)) package with Bioconductor in R.
(B) Quantitative RT-PCR confirming up-regulation of egl-
15 and sur-7 in smo-1lf bet-1lf mutants. At least three
independent samples were used. P values calculated using
the Student T test and error bars are +/2 SEM.
SUMO and BET-1 maintain muscle myosin levels in adults 6
B
io
lo
g
y
O
p
e
n
hyperactivation of the EGL-15/LET-60/LIN-45/MEK-2
signalling pathway that in turn could initiate muscle myosin
depletion. We dampened the LET-60 signalling pathway using
the MEK inhibitor U0126 (Morgan et al., 2010) and measured the
effect on muscle myosin levels at day four adult. Remarkably, we
found that U0126-treated smo-1lf bet-1lf double mutants can
maintain muscle myosin levels. 32% of DMSO-treated smo-1lf
bet-1lf animals displayed depletion of muscle myosin compared
with 2% of U0126-treated animals (Fig. 4A). Importantly, this
experiment indicates that the conserved FGF receptor/RAS/RAF/
MEK signalling pathway is required for the muscle myosin
depletion phenotype to manifest. It is also consistent with other
studies linking hyperactivation of the LET-60 signalling pathway
with protein degradation in muscles (Szewczyk and Jacobson,
2003; Szewczyk et al., 2007; Szewczyk et al., 2002).
Since we found that egl-15 and sur-7 are overexpressed in
double mutants (Fig. 3A), we next addressed specifically whether
these could play an important role in the muscle myosin depletion
phenotype. To this end, we depleted smo-1lf bet-1lf double
mutants of egl-15 by either performing RNAi or using a reduced
function allele; we found that the penetrance of the myosin
depletion phenotype is decreased by 56%, from 34% to 15%,
(P50.001; Table 1) and by 35%, from 34% to 22%, (P50.042;
Table 1), respectively. We also tested sur-7 (RNAi) and observed
a decrease in the penetrance by 70%, from 34% to 11%
(P,0.001; Table 1). Thus, the overexpression of EGL-15 and
SUR-7, the rescue experiments by the MEK inhibitor, and
depletion of either EGL-15 or SUR-7 taken together provide
strong evidence that the EGL-15/LET-60/MEK signalling
pathway is required for the muscle myosin depletion phenotype
to fully manifest.
Hypodermal depletion of egl-15 or sur-7 rescues the muscle
myosin phenotype
It has been previously shown that the EGL-15/LET-60/LIN-45/
MEK-2 signalling cascade, in addition to producing the muscle
cell proteolysis defect, can also cause a Clr phenotype (Huang
and Stern, 2004; Kokel et al., 1998). Of note, clr-1 mutants do not
display the muscle myosin depletion phenotype (Table 1) and are
morphologically different from the double smo-1lf bet-1lf
mutants (supplementary material Fig. S3). The exact relationship
between the muscle proteolysis defect and the Clr phenotype
remains unclear. However, the anatomical locus of activity for
the EGL-15 signalling cascade, to produce the Clr phenotype, is
the hypoderm (Huang and Stern, 2004) rather than the muscles
itself. With this in mind, we sought to identify the tissue in which
EGL-15 and SUR-7 are required to produce muscle myosin
depletion. To this end, we performed hypodermal and body wall
muscle specific RNAi against egl-15 and sur-7. This established
tissue specific RNAi system takes advantage of an RNAi
insensitive strain lacking RDE-1, in which tissue-specific re-
expression of RDE-1 reactivates RNAi sensitivity in the targeted
tissue (Qadota et al., 2007). We assessed whether knocking down
egl-15 or sur-7 in either the hypoderm or the body wall muscles
could rescue the muscle myosin depletion phenotype. We found
that only hypodermal RNAi, of either egl-15 or sur-7, can do so.
Depleting EGL-15 or SUR-7 reduces the penetrance by 47% and
50%, from 32% down to 17% (P50.016) and 16% (P50011),
respectively (Table 2). No rescuing effect could be detected by
targeting either egl-15 or sur-7 in body wall muscles. Since we
cannot rule out discrepancies in RNAi efficiency, we cannot rule
out the possibility of a muscle activity (Table 2). Despite this
caveat, these data show that hypodermal EGL-15 (and SUR-7)
signalling is implicated in the depletion of muscle myosin
phenotype.
JQ1-treated SUMO mutants display the muscle myosin
depletion phenotype
So far we have shown that BET-1 acts together with the
sumoylation pathway to prevent muscle myosin depletion in
adults. We next wanted to address whether the recognition of
acetyl-lysines is important in the depletion of muscle phenotype.
We blocked reading of acetyl-lysines using a small molecule
compound inhibitor of BET proteins, JQ1 (Dawson et al., 2011;
Fig. 4. Immunofluorescence against MYO-3 on U0126-treated smo-1lf bet-
1lf mutants or JQ1-treated smo-1lf mutants. (A) U0126-treated smo-1lf bet-1lf
mutants do not display the depletion of muscle myosin phenotype. Percentages
refer to animals displaying the depletion of muscle myosin phenotype with the
number of animals analysed indicated. (B) Photograph of JQ1-treated smo-1lf
mutant that mimics the depletion of muscle myosin phenotype. (C) The smo-1lf
animals were exposed to either the control DMSO or JQ1 at the indicated
concentrations. At least 50 animals were analysed for each condition. JQ1-
treated wild type worms do not display the depletion of muscle myosin
phenotype (not shown).
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Delmore et al., 2011; Filippakopoulos et al., 2010; Nicodeme
et al., 2010; Zuber et al., 2011). If recognition of acetyl-lysines is
involved, we should detect the muscle myosin depletion
phenotype when smo-1lf animals are treated with increasing
amount of JQ1 (2.5, 10 and 25 mM). Using immunostaining, we
found that JQ1-treated smo-1lf animals indeed display the muscle
myosin depletion phenotype (Fig. 4B,C). JQ1 treatment of wild
type animals did not cause the depletion of muscle myosin
phenotype (data not shown). From this, we concluded that
recognition of acetyl-lysines is important to prevent depletion of
muscle myosin in adults. Since it is likely that most of these
recognised acetyl-lysines are on histone tails, the data suggest
that the muscle myosin depletion phenotype implicates a defect at
the epigenetic level. Of note, we confirmed that JQ1 can block
BET-1’s association with acetyl-lysines on histones using FRAP
(supplementary material Fig. S4), in accordance with another
study showing that BET-1 can associate with acetylated histones
(Shibata et al., 2010).
Discussion
This study provides novel mechanistic insights into the pathways
that ensure maintenance of muscle myosin levels in ageing adults
and likely to influence the complex behaviour of locomotion. We
present a novel muscle phenotype characterised by the depletion
of adult muscle myosin. Our investigation shows a number of
specific characteristics associated with this phenotype: it is
caspase- and MEK-dependent, it requires hypodermal EGL-15
activity, and the muscle myosin depletion is observed only in
adults and getting progressively more severe as the animals are
ageing.
Transcriptional regulation of EGL-15 and SUR-7
We have found that in absence of BET-1 and SMO-1 the FGF
receptor, egl-15, and the cation diffusion facilitator sur-7 are up-
regulated. Since BET-1 associates with acteyl-lysines on histone
tails (supplementary material Fig. S4) (Shibata et al., 2010), it is a
possibility that their expression are regulated by this histone
modification and therefore implicating an epigenetic mechanism.
This possibility is consistent with our experiments showing that
the ability to recognise acetyl-lysines is crucial to prevent muscle
myosin depletion in adults (Fig. 4B,C). However, the up-
regulation of both sur-7 and egl-15 (Fig. 3) suggests that
acetyl-lysines could be interpreted as a signal for repression by
BET-1, even though acetyl-lysines on histone tails are generally
associated with activation of transcription. An alternative
explanation for this repression effect is that BET-1 could be
required to maintain the expression of a repressor that in turn acts
on sur-7 and egl-15. Further work will be needed to distinguish
between these mechanisms.
Non-cell autonomous EGL-15 activity
It is intriguing that the depletion of muscle myosin phenotype is
apparent only in adults (in non-dividing cells), suggesting an
important role for BET-1 and SMO-1 in muscle myosin
homeostasis. Furthermore, we show that this phenotype is
likely to involve a non-cell-autonomous mechanism.
Interestingly, previous mosaic analysis on the Clear phenotype
caused by hyperactivation of LET-60 signalling revealed that the
anatomical locus of activity for the EGL-15 signalling cascade is
hypodermal (Huang and Stern, 2004). Similarly, muscle myosin
depletion is influenced by hypodermal EGL-15 activity
(Table 2). Even though it is not obvious how hyperactivation
of the EGL-15 signalling in the hypoderm can lead to muscle
myosin depletion, there is a physical association between the
muscles and the hypoderm. A recent report has shown that
calpains mediate integrin attachment complex maintenance of
adult muscles in C. elegans (Etheridge et al., 2012). Integrin
attachment complexes fulfil multiple functions in muscles
(Moerman and Williams, 2006), one of which is to anchor
body wall muscles to the basement membrane. Since hypodermal
cells are also linked to the basement membrane (Moerman and
Williams, 2006) this physical association could mediate
signalling events between muscles and hypodermis. Hence,
hyperactivation of the EGL-15/LET-60/MEK signalling pathway
in the hypoderm could produce a defect in signalling events
between muscle and hypoderm, leading to the muscle myosin
depletion phenotype.
Premature loss of locomotion and depletion of muscle myosin
We have found that loss of locomotion occurs prematurely in
single and especially in double smo-1lf bet-1lf mutants. Loss of
locomotion can be observed before the depletion of muscle
myosin. This sequence of events strongly suggests that another
function impacting on locomotion is impaired in these mutants.
Locomotion is a complex behaviour involving muscles, neurons
and muscle attachments to the cuticle via the hypoderm. We have
shown that a defect in signalling occurs in the hypoderm and that
muscle cells are depleted in muscle myosin. It remains to be
investigated whether neurons are affected, since BET-1 has been
shown to act in stabilising neuronal cell fate (Shibata et al.,
2010). It is also a possibility that the loss of locomotion is the
primary defect, leading to the depletion of muscle myosin. There
is however a discrepancy between the percentage of animals
losing locomotion and the percentage of animals depleted in
muscle myosin; there are at least twice as many animals losing
locomotion that there are animals depleted in muscle myosin.
Further, inactivation of CED-3 in smo-1lf bet-1lf mutants allowed
maintenance of muscle myosin levels. However, we observe the
same discrepancy aforementioned between loss of locomotion at
day four and depletion of muscle myosin. Thus, the depletion of
Table 2. EGL-15 and SUR-7 are active in the hypoderm. The depletion of muscle myosin (Demm) phenotype was assessed using
immunostaining against muscle myosin. Significant p values of 0.0111 and 0.0162 by chi square test of association.
Genotype N % Demm
EV(RNAi) ; smo-1 bet-1;rde-1; kzis9 (hypoderm) 104 32
egl-15(RNAi); smo-1 bet-1;rde-1; kzis9 (hypoderm) 51 171
sur-7(RNAi); smo-1 bet-1; rde-1; kzis9 (hypoderm) 85 162
EV(RNAi) ; smo-1 bet-1; rde-1; kzis20 (muscle) 152 26
egl-15(RNAi); smo-1 bet-1;rde-1;kzis20 (muscle) 50 24
sur-7(RNAi); smo-1 bet-1; rde-1; kzis20 (muscle) 82 27
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muscle myosin, at day four adult, appears unlikely to be induced
by loss of locomotion. Unless, a number of animals have been in
an immobilised state longer than others prior to analysis and that
those particular animals are depleted in muscle myosin.
Finally, the muscle myosin depletion phenotype that we
described produces an effect resembling muscle atrophy.
However, it is unclear whether this phenotype is actually a
premature manifestation of sarcopenia, the loss of muscle mass
due to ageing, which occurs naturally in C. elegans (Herndon
et al., 2002) or whether it is a muscular pathology. Taken
together, our study has identified bet-1 and smo-1 as important
players in the maintenance of adult muscle myosin levels through
a caspase- and MEK-dependent mechanism, which could be
relevant to muscle ageing and/or a muscle pathology.
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